Poly (l-lactic acid) bioresorbable scaffolds versus metallic drug-eluting stents for the treatment of coronary artery disease: A meta-analysis of 11 randomized trials.
Monica VerdoiaElvin KedhiHarry SuryapranataGennaro GalassoDariusz DudekGiuseppe De LucaPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
The present meta-analysis provides the most updated data on the use of PLLA-BVS for the treatment of CAD. We documented a poorer performance of these new coronary devices, as compared to new generation metallic DES, being associated with an increased rate of recurrent cardiovascular events. However, such ischemic complications did not impact on mortality, with a comparable survival independently from the type of stent.
Keyphrases
- coronary artery disease
- cardiovascular events
- systematic review
- percutaneous coronary intervention
- coronary artery bypass grafting
- lactic acid
- risk factors
- randomized controlled trial
- heart failure
- big data
- machine learning
- emergency department
- smoking cessation
- left ventricular
- aortic valve
- acute coronary syndrome
- blood brain barrier
- adverse drug